Good news! If the test in monkeys is successful, the Covid-19 vaccine may be available by September

Good news!

Oxford COVID-19 vaccine shows positive effects in monkeys;  Serum Institute of India will produce it in bulk within months

Monkeys received a dose of the vaccine developed by Oxford University scientists and remain infection-free four weeks after being exposed to the virus

Covid-19 vaccine - Key highlights

• Six monkeys fed ChAdOx1 nCoV-19 were exposed to large number of coronaviruses, but none of them were infected with the virus
• Serum Institute of India (SII) has announced that it is planning to produce the vaccine in the next two to three weeks.
• Scientists at Oxford University (England) launch vaccine injection experiments last week

No signs of Covid-19 were detected after vaccination

Rhesus macaque monkeys

Vaccine against Covid-19 was tested in monkeys.

• Macaque monkeys have been vaccinated with a vaccine developed by Oxford University scientists, and four weeks later, the monkeys remain infected, the New York Times reports.
• In addition, MirrorOnline reports that the new vaccine tested in more than 6,000 people is safe and effective.

Experts from the University of Oxford are working to develop a vaccine

• The university claims that if the vaccine was successful, authorities would give it immediate permission and millions of doses would be available by September.
• Lead researcher Dr Vincent Munster for the National Institutes of Health's Rocky Mountain Laboratory said the species of monkey used is "the closest thing we have to humans".

• 100 potential Covid-19 vaccines currently under development, at least five are currently undergoing initial testing in humans for Phase One clinical trials
• One of these vaccines was first tested in Europe last week.

• The vaccines was injected in two volunteers, and more than 800 people were recruited for the first study.
• Reithera of Italy, Germany's LeucoCare, and Belgium's Universals say they are likely to work together and are launching experiments in a few months

• Britain's GSK and France's Sanofi last week announced a similar agreement to develop a COVID-19 vaccine, with trials starting in the second half of the year.
• There is no guarantee the vaccine will be successful on humans but Dr Munster plans to submit his research to a peer-reviewed journal.

• New Delhi: The experimental COVID-19 vaccine, developed by Oxford University, has shown excellent results in animal experiments, raising the prospect of a safe vaccine against fatal respiratory infections.
• Serum Institute of India (SII) recently revealed that it will start producing Covid-19 vaccine within the next two to three weeks. The world's largest vaccine maker, the Pune-based Comapany has announced that the vaccine will be available for use by October if human clinical trials are successful.

• The vaccine is expected to produce up to 60 million doses
• Adar Poonawalla, CEO of Serum Institute of India (SII), said the vaccine is expected to hit the market by September-October (Covid-19) if the tests are successful. Poonawalla added that we will start testing for this vaccine in India within the next 2-3 weeks.
  
• Since its first outbreak in China in December 2019, more than 4,649,079 people have been infected with COVID-19 in 193 countries and territories, and more than 309,047 people have died.

Follow us on facebook : https://www.facebook.com/tecnshop.techy

News Source : Cambridge News,Times Now News